ArticleCancer medicine2026
Cancer Incidence in People With Intellectual Disability and Down Syndrome in Australia: A Cohort Study.
Article in Cancer medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectiveThere is inconsistent data on cancer risk in people with intellectual disability. Our primary objective was to compare the incidence of cancer in people with and without intellectual disability. METHODS AND ANALYSIS: A cohort study using linked population-based administrative and cancer registry data in New South Wales, Australia 2001-2018. We compared the incidence of cancer in people with intellectual disability and a comparator group without intellectual disability matched for age, sex and residential postcode. We also compared cancer incidence in people with Down syndrome and people with intellectual disability without Down syndrome. We used a flexible parametric survival model accounting for competing risks.
resultsPeople with intellectual disability had a slightly higher risk of developing any cancer (sub-hazard ratio, SHR 1.07 [95% CI 1.03 to 1.12]) compared to those without intellectual disability. An increased risk was evident in the 0-14 year (SHR 2.19, 95% CI 1.85 to 2.59) and 15-49 year (SHR 1.34, 95% CI 1.23 to 1.46) age groups, and a decreased risk was observed for those aged 50 years and above (SHR 0.93, 95% CI 0.88 to 0.98). People with intellectual disability had a higher risk of colorectal cancer (SHR 1.32, 95% CI 1.15 to 1.51) and a lower risk of prostate cancer (SHR 0.45, 95% CI 0.38 to 0.53) and melanoma (SHR 0.75, 95% CI 0.64 to 0.88). People with Down syndrome had a significantly higher risk of childhood cancer (SHR 7.94, 95% CI 5.72 to 11.04) compared to those with other intellectual disability, and a similar risk as an adult.
conclusionsThese findings underscore the need for targeted health promotion campaigns and, for adults, customised cancer screening programmes to improve access, acceptability and outcomes for people with intellectual disability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.